a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ETNB has been closely correlated with AKRO. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if ETNB jumps, then AKRO could also see price increases.
Ticker / NAME | Correlation To ETNB | 1D Price Change % | ||
---|---|---|---|---|
ETNB | 100% | -7.58% | ||
AKRO - ETNB | 78% Closely correlated | -4.45% | ||
PRME - ETNB | 39% Loosely correlated | -9.81% | ||
PLRX - ETNB | 37% Loosely correlated | -3.84% | ||
NTLA - ETNB | 36% Loosely correlated | -3.65% | ||
PTGX - ETNB | 35% Loosely correlated | -3.45% | ||
More |